EMEA-000987-PIP01-10-M04
Key facts
Invented name |
Strensiq
|
Active substance |
asfotase alfa
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0176/2019
|
PIP number |
EMEA-000987-PIP01-10-M04
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of hypophosphatasia
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
Alexion Europe SAS
Tel. +33 153643800 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000987-PIP01-10-M04
|
Compliance opinion date |
18/10/2019
|
Compliance outcome |
positive
|